@article{6888e4001b1b4b90b1f15b7f9a5e233f,
title = "Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus: The IDDIA Trial",
keywords = "diabetes mellitus, diastole, echocardiography, stress, function, sodium-glucose transporter 2 inhibitors",
author = "Shim, {Chi Young} and Jiwon Seo and Iksung Cho and Lee, {Chan Joo} and Cho, {In Jeong} and Purevjargal Lhagvasuren and Kang, {Seok Min} and Ha, {Jong Won} and Gyoonhee Han and Yangsoo Jang and Hong, {Geu Ru}",
note = "Funding Information: The IDDIA trial was an investigator-initiated trial funded by AstraZeneca. All analyses were conducted independently, and all authors had full access to the data. The authors are fully responsible for the study design; the collection, analysis and interpretation of the data; and the writing of the manuscript. The sponsor played no role in the decision to submit the manuscript for publication. This research was also supported by a grant of the Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI20C1566).",
year = "2021",
month = feb,
day = "2",
doi = "10.1161/CIRCULATIONAHA.120.051992",
language = "English",
volume = "143",
pages = "510--512",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "5",
}